Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bovine Thioredoxin (TXN) ELISA Kit-Sandwich

Cat. No.EK11F911

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Bovine Thioredoxin (TXN) ELISA Kit-Sandwich is designed for the quantitative determination of Bovine Thioredoxin (TXN) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Bovine TXN.
Target Species Bovine
Species Reactivity Bovine
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 270 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Thioredoxin (TRX or TXN) is a class of small redox proteins present in all organisms. It plays a role in many important biological processes, including redox signaling. Bovine Thioredoxin is encoded by the TXN gene in cattle. It is a member of the thioredoxin family, and is a regulator of redox balance through the dynamic transformation between its oxidized and reduced states.

Target/Biomarker Bovine TXN
Target Synonym thioredoxin; trx
Gene ID 280950
UniProt ID O97680

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Liu, X. et al. Identification of thioredoxin-1 as a biomarker of lung cancer and evaluation of its prognostic value based on bioinformatics analysis. Frontiers in oncology. 2023, 13.
Inquiry Basket